Monsanto Co. (MON) PT Set at $128.00 by JPMorgan Chase & Co.
Several other research analysts also recently commented on MON. Zacks Investment Research upgraded Monsanto from a sell rating to a hold rating in a research note on Wednesday, June 8th. Piper Jaffray Cos. reiterated an overweight rating and set a $127.00 price target (up previously from $95.00) on shares of Monsanto in a research report on Monday, June 13th. Argus reiterated a buy rating and set a $128.00 price target (up previously from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Goldman Sachs Group Inc. set a $92.00 price target on Monsanto and gave the company a sell rating in a research report on Monday, June 27th. Finally, Vetr upgraded Monsanto from a buy rating to a strong-buy rating and set a $116.55 price target for the company in a research report on Monday, June 27th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Monsanto has an average rating of Buy and a consensus target price of $114.65.
Shares of Monsanto (NYSE:MON) opened at 103.33 on Thursday. The company has a 50-day moving average price of $104.80 and a 200 day moving average price of $101.69. Monsanto has a one year low of $83.73 and a one year high of $114.26. The company has a market capitalization of $45.23 billion, a PE ratio of 34.58 and a beta of 1.19.
Monsanto (NYSE:MON) last issued its earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. During the same quarter last year, the company earned ($0.19) EPS. The firm’s revenue was up 8.8% compared to the same quarter last year. Equities analysts anticipate that Monsanto will post $4.89 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date is Wednesday, October 5th. Monsanto’s payout ratio is currently 71.05%.
In other news, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.88% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in MON. WFG Advisors LP increased its position in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the last quarter. Signaturefd LLC increased its position in shares of Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock worth $112,000 after buying an additional 415 shares during the last quarter. Mycio Wealth Partners LLC increased its position in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the last quarter. Pinkerton Retirement Specialists LLC increased its position in shares of Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares during the last quarter. Finally, Carnick & Kubik LLC acquired a new position in shares of Monsanto during the first quarter worth about $130,000. 79.02% of the stock is currently owned by hedge funds and other institutional investors.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.